Pfizer Inc.
Cash Flow Statement
| Line Item | FY2017 | FY2016 | FY2015 | FY2014 | FY2013 | FY2012 | FY2011 | FY2010 |
|---|---|---|---|---|---|---|---|---|
| Operating Activities | ||||||||
| Net Income | $21.31B | $7.22B | $6.96B | $9.14B | $22.00B | $14.57B | $10.01B | $8.26B |
| Depreciation & Amortization | $6.27B | $5.76B | $5.16B | $5.54B | $6.31B | $7.39B | $8.70B | $8.40B |
| Depreciation | — | — | — | — | — | — | — | — |
| Amortization | — | — | $3.80B | $4.10B | $4.80B | $5.30B | $5.70B | $5.50B |
| Stock-Based Compensation | $840.0M | $691.0M | $669.0M | $586.0M | $523.0M | $481.0M | $419.0M | $405.0M |
| Net Cash from Operating Activities | $16.80B | $16.19B | $14.69B | $17.08B | $17.68B | $16.75B | $20.24B | $11.45B |
| Investing Activities | ||||||||
| Capital Expenditures | $1.96B | $1.82B | $1.40B | $1.20B | $1.21B | $1.33B | $1.66B | $1.51B |
| Business Acquisitions | $1.00B | $18.37B | $16.47B | $195.0M | $15.0M | $1.05B | $3.28B | $273.0M |
| Net Cash from Investing Activities | $-4.74B | $-7.79B | $-2.98B | $-5.65B | $-10.54B | $6.15B | $1.84B | $-492.0M |
| Financing Activities | ||||||||
| Dividends Paid | — | — | — | — | — | — | — | — |
| Stock Repurchases | $5.00B | $5.00B | $6.16B | $5.00B | $16.29B | $8.23B | $9.00B | $1.00B |
| Net Cash from Financing Activities | $-13.35B | $-9.23B | $-10.41B | $-10.19B | $-14.98B | $-16.00B | $-20.61B | $-11.17B |
| Net Change in Cash | $-1.25B | $-1.05B | $298.0M | $1.16B | $-7.90B | $6.90B | $1.45B | $-243.0M |
| Free Cash Flow | $14.85B | $14.37B | $13.29B | $15.89B | $16.48B | $15.42B | $18.58B | $9.94B |